Home ➤ Life Science ➤ Biotechnology ➤ Antibody Therapeutics Market
Antibody Therapeutics Market
Published date: June 2025 • Formats:
Request Sample Schedule a Call

Antibody Therapeutics Market By Product Type (Monoclonal Antibodies (mAbs) and Antibody-drug Conjugates (ADCs)), By Source (Human mAb, Murine mAb, Humanized mAb, and Chimeric mAb), By Application (Cancer, Inflammatory Diseases, Infectious Diseases, Autoimmune Diseases, and Others), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

  • Published date: June 2025
  • Report ID: 130808
  • Number of Pages: 296
  • Format:
  • keyboard_arrow_up
    • 1. Executive Summary
      • 1.1. Definition
      • 1.2. Market Snapshot
      • 1.3. Market Overview
      • 1.4. Segment Overview
      • 1.5. Regional Overview
      • 1.6. Competitive Landscape
      • 1.7. Taxonomy
      • 1.8. Industry Voices
    • 2. Global Market Overview
      • 2.1. Global Market Insights and Industry Overview
      • 2.2. Market Dynamics
        • 2.2.1. Drivers
        • 2.2.2. Restraints
        • 2.2.3. Opportunities
        • 2.2.4. Key Antibody Therapeutics Market Trends
      • 2.3. Technology Landscape
      • 2.4. Regulatory Framework
      • 2.5. Sustainability and ESG (Environmental, Social, Governance)
      • 2.6. Opportunity Map Analysis
      • 2.7. Opportunity Orbits
      • 2.8. PESTLE Analysis
      • 2.9. PORTER’S Five Force Analysis
      • 2.10. Drivers & Restraints Impact Analysis
      • 2.11. Value Chain Analysis
        • 2.11.1. List of Raw Materials Suppliers
        • 2.11.2. List of Antibody Therapeutics Manufacturers
        • 2.11.3. List of Dealer/Distributors
      • 2.12. Regional Market Share and BPS Analysis
      • 2.13. Impact of Macro-economic Factors/Geopolitical Factors
    • 3. Global Antibody Therapeutics Market Analysis and Forecast, By Segment, 2020-2034
      • 3.1. Key Findings
      • 3.2. Global Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 3.3. Global Antibody Therapeutics Market Attractiveness Analysis, By Product Type
        • 3.3.1. Monoclonal Antibodies (mAbs)
          • 3.3.1.1. Insights
          • 3.3.1.2. Key Takeaways
        • 3.3.2. Antibody-Drug Conjugates (ADCs)
          • 3.3.2.1. Insights
          • 3.3.2.2. Key Takeaways
      • 3.4. Global Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
      • 3.5. Global Antibody Therapeutics Market Attractiveness Analysis, By Source
        • 3.5.1. Human mAb
          • 3.5.1.1. Insights
          • 3.5.1.2. Key Takeaways
        • 3.5.2. Murine mAb
          • 3.5.2.1. Insights
          • 3.5.2.2. Key Takeaways
        • 3.5.3. Humanized mAb
          • 3.5.3.1. Insights
          • 3.5.3.2. Key Takeaways
        • 3.5.4. Chimeric mAb
          • 3.5.4.1. Insights
          • 3.5.4.2. Key Takeaways
      • 3.6. Global Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 3.7. Global Antibody Therapeutics Market Attractiveness Analysis, By Application
        • 3.7.1. Cancer
          • 3.7.1.1. Insights
          • 3.7.1.2. Key Takeaways
        • 3.7.2. Inflammatory Diseases
          • 3.7.2.1. Insights
          • 3.7.2.2. Key Takeaways
        • 3.7.3. Infectious Diseases
          • 3.7.3.1. Insights
          • 3.7.3.2. Key Takeaways
        • 3.7.4. Autoimmune Diseases
          • 3.7.4.1. Insights
          • 3.7.4.2. Key Takeaways
        • 3.7.5. Others
          • 3.7.5.1. Insights
          • 3.7.5.2. Key Takeaways
      • 3.8. Global Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 3.9. Global Antibody Therapeutics Market Attractiveness Analysis, By End-user
        • 3.9.1. Hospital Pharmacy
          • 3.9.1.1. Insights
          • 3.9.1.2. Key Takeaways
        • 3.9.2. Retail Pharmacy
          • 3.9.2.1. Insights
          • 3.9.2.2. Key Takeaways
        • 3.9.3. Online Pharmacy
          • 3.9.3.1. Insights
          • 3.9.3.2. Key Takeaways
    • 4. Global Antibody Therapeutics Market Analysis and Forecast, By Region, 2020-2034
      • 4.1. Key Findings
      • 4.2. Global Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
        • 4.2.1. North America
          • 4.2.1.1. Regional Insights
        • 4.2.2. Europe
          • 4.2.2.1. Regional Insights
        • 4.2.3. Asia Pacific
          • 4.2.3.1. Regional Insights
        • 4.2.4. Latin America
          • 4.2.4.1. Regional Insights
        • 4.2.5. Middle East & Africa
          • 4.2.5.1. Regional Insights
      • 4.3. Global Antibody Therapeutics Market Attractiveness Analysis, By Region
    • 5. North America Antibody Therapeutics Market Analysis and Forecast, 2020-2034
      • 5.1. Key Findings
      • 5.2. North America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 5.3. North America Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • 5.4. North America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
      • 5.5. North America Antibody Therapeutics Market Attractiveness Analysis, By Source
      • 5.6. North America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 5.7. North America Antibody Therapeutics Market Attractiveness Analysis, By Application
      • 5.8. North America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 5.9. North America Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • 5.10. North America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 5.11. North America Antibody Therapeutics Market Attractiveness Analysis, By Country
        • 5.11.1. The US
        • 5.11.2. Canada
    • 6. Europe Antibody Therapeutics Market Analysis and Forecast, 2020-2034
      • 6.1. Key Findings
      • 6.2. Europe Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 6.3. Europe Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • 6.4. Europe Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
      • 6.5. Europe Antibody Therapeutics Market Attractiveness Analysis, By Source
      • 6.6. Europe Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 6.7. Europe Antibody Therapeutics Market Attractiveness Analysis, By Application
      • 6.8. Europe Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 6.9. Europe Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • 6.10. Europe Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 6.11. Europe Antibody Therapeutics Market Attractiveness Analysis, By Country
        • 6.11.1. Germany
        • 6.11.2. The UK
        • 6.11.3. France
        • 6.11.4. Spain
        • 6.11.5. Italy
        • 6.11.6. Russia
        • 6.11.7. Netherland
        • 6.11.8. Rest of Europe
    • 7. Asia Pacific Antibody Therapeutics Market Analysis and Forecast, 2020-2034
      • 7.1. Key Findings
      • 7.2. Asia Pacific Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 7.3. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • 7.4. Asia Pacific Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
      • 7.5. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Source
      • 7.6. Asia Pacific Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 7.7. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Application
      • 7.8. Asia Pacific Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 7.9. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • 7.10. Asia Pacific Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 7.11. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Country
        • 7.11.1. China
        • 7.11.2. Japan
        • 7.11.3. South Korea
        • 7.11.4. India
        • 7.11.5. Australia
        • 7.11.6. New Zealand
        • 7.11.7. Singapore
        • 7.11.8. Thailand
        • 7.11.9. Vietnam
        • 7.11.10. Rest of Asia Pacific
    • 8. Latin America Antibody Therapeutics Market Analysis and Forecast, 2020-2034
      • 8.1. Key Findings
      • 8.2. Latin America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 8.3. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • 8.4. Latin America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
      • 8.5. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Source
      • 8.6. Latin America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 8.7. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Application
      • 8.8. Latin America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 8.9. Latin America Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • 8.10. Latin America Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 8.11. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Country
        • 8.11.1. Brazil
        • 8.11.2. Mexico
        • 8.11.3. Rest of Latin America
    • 9. Middle East & Africa Antibody Therapeutics Market Analysis and Forecast, 2020-2034
      • 9.1. Key Findings
      • 9.2. Middle East & Africa Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
      • 9.3. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • 9.4. Middle East & Africa Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Source, 2020-2034
      • 9.5. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Source
      • 9.6. Middle East & Africa Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Application, 2020-2034
      • 9.7. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Application
      • 9.8. Middle East & Africa Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By End-user, 2020-2034
      • 9.9. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • 9.10. Middle East & Africa Antibody Therapeutics Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
      • 9.11. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Country
        • 9.11.1. South Africa
        • 9.11.2. Saudi Arabia
        • 9.11.3. UAE
        • 9.11.4. Rest of Middle East & Africa
    • 10. Competitive Landscape & Company Profiles
      • 10.1. Market Competition Scenario Analysis, By Company
        • 10.1.1. Key Takeaways
      • 10.2. Overview of Major Market Players
      • 10.3. Competitor Landscape
      • 10.4. Strategic Mapping
      • 10.5. Company Life Cycle Analysis
      • 10.6. Company Market Share Analysis
      • 10.7. Company Profiles
        • 10.7.1. Hiedelberg Pharma A/G
          • 10.7.1.1. Company Details
          • 10.7.1.2. Business Overview
          • 10.7.1.3. Product Portfolio
          • 10.7.1.4. Financial Insights
          • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.1.6. SWOT Analysis
          • 10.7.1.7. Geographic Footprint
        • 10.7.2. Taiho Pharmaceutical Co., Ltd
          • 10.7.2.1. Company Details
          • 10.7.2.2. Business Overview
          • 10.7.2.3. Product Portfolio
          • 10.7.2.4. Financial Insights
          • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.2.6. SWOT Analysis
          • 10.7.2.7. Geographic Footprint
        • 10.7.3. GlaxoSmithKline
          • 10.7.3.1. Company Details
          • 10.7.3.2. Business Overview
          • 10.7.3.3. Product Portfolio
          • 10.7.3.4. Financial Insights
          • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.3.6. SWOT Analysis
          • 10.7.3.7. Geographic Footprint
        • 10.7.4. ImmunoPrecise Antibodies Ltd
          • 10.7.4.1. Company Details
          • 10.7.4.2. Business Overview
          • 10.7.4.3. Product Portfolio
          • 10.7.4.4. Financial Insights
          • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.4.6. SWOT Analysis
          • 10.7.4.7. Geographic Footprint
        • 10.7.5. Genmab A/S
          • 10.7.5.1. Company Details
          • 10.7.5.2. Business Overview
          • 10.7.5.3. Product Portfolio
          • 10.7.5.4. Financial Insights
          • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.5.6. SWOT Analysis
          • 10.7.5.7. Geographic Footprint
        • 10.7.6. Genentech, Inc
          • 10.7.6.1. Company Details
          • 10.7.6.2. Business Overview
          • 10.7.6.3. Product Portfolio
          • 10.7.6.4. Financial Insights
          • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.6.6. SWOT Analysis
          • 10.7.6.7. Geographic Footprint
        • 10.7.7. AstraZeneca
          • 10.7.7.1. Company Details
          • 10.7.7.2. Business Overview
          • 10.7.7.3. Product Portfolio
          • 10.7.7.4. Financial Insights
          • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.7.6. SWOT Analysis
          • 10.7.7.7. Geographic Footprint
        • 10.7.8. ADC Therapeutics
          • 10.7.8.1. Company Details
          • 10.7.8.2. Business Overview
          • 10.7.8.3. Product Portfolio
          • 10.7.8.4. Financial Insights
          • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
          • 10.7.8.6. SWOT Analysis
          • 10.7.8.7. Geographic Footprint
    • 11. Methodology and Data Source
      • 11.1. Methodology/Research Approach
      • 11.2. Market Size Estimation
      • 11.3. Market Breakdown and Data Triangulation
      • 11.4. Data Source
      • 11.5. Secondary Sources
      • 11.6. Primary Sources
      • 11.7. Appendix
      • 11.8. Disclaimer
    • List of Tables
      • Table 1. Global Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 2. Global Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 3. Global Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 4. Global Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 5. Global Antibody Therapeutics Market Value (US$ Mn), By Region, 2020-2034
      • Table 6. North America Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 7. North America Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 8. North America Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 9. North America Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 10. North America Antibody Therapeutics Market Value (US$ Mn), By Country, 2020-2034
      • Table 11. The US Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 12. The US Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 13. The US Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 14. The US Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 15. Canada Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 16. Canada Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 17. Canada Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 18. Canada Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 19. Europe Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 20. Europe Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 21. Europe Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 22. Europe Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 23. Europe Antibody Therapeutics Market Value (US$ Mn), By Country, 2020-2034
      • Table 24. Germany Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 25. Germany Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 26. Germany Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 27. Germany Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 28. The UK Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 29. The UK Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 30. The UK Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 31. The UK Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 32. France Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 33. France Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 34. France Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 35. France Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 36. Spain Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 37. Spain Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 38. Spain Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 39. Spain Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 40. Italy Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 41. Italy Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 42. Italy Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 43. Italy Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 44. Russia Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 45. Russia Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 46. Russia Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 47. Russia Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 48. Netherland Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 49. Netherland Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 50. Netherland Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 51. Netherland Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 52. Rest of Europe Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 53. Rest of Europe Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 54. Rest of Europe Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 55. Rest of Europe Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 56. Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 57. Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 58. Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 59. Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 60. Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Country, 2020-2034
      • Table 61. China Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 62. China Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 63. China Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 64. China Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 65. India Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 66. India Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 67. India Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 68. India Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 69. Japan Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 70. Japan Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 71. Japan Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 72. Japan Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 73. South Korea Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 74. South Korea Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 75. South Korea Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 76. South Korea Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 77. Australia Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 78. Australia Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 79. Australia Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 80. Australia Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 81. New Zealand Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 82. New Zealand Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 83. New Zealand Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 84. New Zealand Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 85. Singapore Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 86. Singapore Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 87. Singapore Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 88. Singapore Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 89. Thailand Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 90. Thailand Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 91. Thailand Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 92. Thailand Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 93. Vietnam Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 94. Vietnam Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 95. Vietnam Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 96. Vietnam Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 97. Rest of Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 98. Rest of Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 99. Rest of Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 100. Rest of Asia Pacific Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 101. Latin America Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 102. Latin America Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 103. Latin America Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 104. Latin America Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 105. Latin America Antibody Therapeutics Market Value (US$ Mn), By Country, 2020-2034
      • Table 106. Brazil Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 107. Brazil Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 108. Brazil Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 109. Brazil Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 110. Mexico Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 111. Mexico Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 112. Mexico Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 113. Mexico Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 114. Rest of Latin America Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 115. Rest of Latin America Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 116. Rest of Latin America Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 117. Rest of Latin America Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 118. Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 119. Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 120. Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 121. Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 122. Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Country, 2020-2034
      • Table 123. South Africa Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 124. South Africa Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 125. South Africa Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 126. South Africa Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 127. Saudi Arabia Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 128. Saudi Arabia Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 129. Saudi Arabia Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 130. Saudi Arabia Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 131. UAE Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 132. UAE Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 133. UAE Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 134. UAE Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
      • Table 135. Rest of Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Product Type, 2020-2034
      • Table 136. Rest of Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Source, 2020-2034
      • Table 137. Rest of Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By Application, 2020-2034
      • Table 138. Rest of Middle East & Africa Antibody Therapeutics Market Value (US$ Mn), By End-user, 2020-2034
    • List of Figures
      • Figure 1. Global Antibody Therapeutics Market Snapshot: Market Value (US$ Mn), 2020-2034
      • Figure 2. Opportunity Map
      • Figure 3. Opportunity Orbit
      • Figure 4. Regional Market Share and BPS Analysis in Antibody Therapeutics Market
      • Figure 5. Global Antibody Therapeutics Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 6. Global Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • Figure 7. Global Antibody Therapeutics Market Analysis, By Source, 2020, 2024 and 2034
      • Figure 8. Global Antibody Therapeutics Market Attractiveness Analysis, By Source
      • Figure 9. Global Antibody Therapeutics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 10. Global Antibody Therapeutics Market Attractiveness Analysis, By Application
      • Figure 11. Global Antibody Therapeutics Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 12. Global Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • Figure 13. Global Antibody Therapeutics Market Analysis, By Region, 2020, 2024 and 2034
      • Figure 14. Global Antibody Therapeutics Market Attractiveness Analysis, By Region
      • Figure 15. North America Antibody Therapeutics Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 16. North America Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • Figure 17. North America Antibody Therapeutics Market (US$ Mn), by Monoclonal Antibodies (mAbs), 2020-2034
      • Figure 18. North America Antibody Therapeutics Market (US$ Mn), by Antibody-Drug Conjugates (ADCs), 2020-2034
      • Figure 19. North America Antibody Therapeutics Market Analysis, By Source, 2020, 2024 and 2034
      • Figure 20. North America Antibody Therapeutics Market Attractiveness Analysis, By Source
      • Figure 21. North America Antibody Therapeutics Market (US$ Mn), by Human mAb, 2020-2034
      • Figure 22. North America Antibody Therapeutics Market (US$ Mn), by Murine mAb, 2020-2034
      • Figure 23. North America Antibody Therapeutics Market (US$ Mn), by Humanized mAb, 2020-2034
      • Figure 24. North America Antibody Therapeutics Market (US$ Mn), by Chimeric mAb, 2020-2034
      • Figure 25. North America Antibody Therapeutics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 26. North America Antibody Therapeutics Market Attractiveness Analysis, By Application
      • Figure 27. North America Antibody Therapeutics Market (US$ Mn), by Cancer, 2020-2034
      • Figure 28. North America Antibody Therapeutics Market (US$ Mn), by Inflammatory Diseases, 2020-2034
      • Figure 29. North America Antibody Therapeutics Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 30. North America Antibody Therapeutics Market (US$ Mn), by Autoimmune Diseases, 2020-2034
      • Figure 31. North America Antibody Therapeutics Market (US$ Mn), by Others, 2020-2034
      • Figure 32. North America Antibody Therapeutics Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 33. North America Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • Figure 34. North America Antibody Therapeutics Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 35. North America Antibody Therapeutics Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 36. North America Antibody Therapeutics Market (US$ Mn), by Online Pharmacy, 2020-2034
      • Figure 37. North America Antibody Therapeutics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 38. North America Antibody Therapeutics Market Attractiveness Analysis, By Country
      • Figure 39. Europe Antibody Therapeutics Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 40. Europe Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • Figure 41. Europe Antibody Therapeutics Market (US$ Mn), by Monoclonal Antibodies (mAbs), 2020-2034
      • Figure 42. Europe Antibody Therapeutics Market (US$ Mn), by Antibody-Drug Conjugates (ADCs), 2020-2034
      • Figure 43. Europe Antibody Therapeutics Market Analysis, By Source, 2020, 2024 and 2034
      • Figure 44. Europe Antibody Therapeutics Market Attractiveness Analysis, By Source
      • Figure 45. Europe Antibody Therapeutics Market (US$ Mn), by Human mAb, 2020-2034
      • Figure 46. Europe Antibody Therapeutics Market (US$ Mn), by Murine mAb, 2020-2034
      • Figure 47. Europe Antibody Therapeutics Market (US$ Mn), by Humanized mAb, 2020-2034
      • Figure 48. Europe Antibody Therapeutics Market (US$ Mn), by Chimeric mAb, 2020-2034
      • Figure 49. Europe Antibody Therapeutics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 50. Europe Antibody Therapeutics Market Attractiveness Analysis, By Application
      • Figure 51. Europe Antibody Therapeutics Market (US$ Mn), by Cancer, 2020-2034
      • Figure 52. Europe Antibody Therapeutics Market (US$ Mn), by Inflammatory Diseases, 2020-2034
      • Figure 53. Europe Antibody Therapeutics Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 54. Europe Antibody Therapeutics Market (US$ Mn), by Autoimmune Diseases, 2020-2034
      • Figure 55. Europe Antibody Therapeutics Market (US$ Mn), by Others, 2020-2034
      • Figure 56. Europe Antibody Therapeutics Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 57. Europe Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • Figure 58. Europe Antibody Therapeutics Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 59. Europe Antibody Therapeutics Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 60. Europe Antibody Therapeutics Market (US$ Mn), by Online Pharmacy, 2020-2034
      • Figure 61. Europe Antibody Therapeutics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 62. Europe Antibody Therapeutics Market Attractiveness Analysis, By Country
      • Figure 63. Asia Pacific Antibody Therapeutics Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 64. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • Figure 65. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Monoclonal Antibodies (mAbs), 2020-2034
      • Figure 66. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Antibody-Drug Conjugates (ADCs), 2020-2034
      • Figure 67. Asia Pacific Antibody Therapeutics Market Analysis, By Source, 2020, 2024 and 2034
      • Figure 68. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Source
      • Figure 69. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Human mAb, 2020-2034
      • Figure 70. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Murine mAb, 2020-2034
      • Figure 71. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Humanized mAb, 2020-2034
      • Figure 72. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Chimeric mAb, 2020-2034
      • Figure 73. Asia Pacific Antibody Therapeutics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 74. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Application
      • Figure 75. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Cancer, 2020-2034
      • Figure 76. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Inflammatory Diseases, 2020-2034
      • Figure 77. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 78. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Autoimmune Diseases, 2020-2034
      • Figure 79. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Others, 2020-2034
      • Figure 80. Asia Pacific Antibody Therapeutics Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 81. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • Figure 82. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 83. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 84. Asia Pacific Antibody Therapeutics Market (US$ Mn), by Online Pharmacy, 2020-2034
      • Figure 85. Asia Pacific Antibody Therapeutics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 86. Asia Pacific Antibody Therapeutics Market Attractiveness Analysis, By Country
      • Figure 87. Latin America Antibody Therapeutics Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 88. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • Figure 89. Latin America Antibody Therapeutics Market (US$ Mn), by Monoclonal Antibodies (mAbs), 2020-2034
      • Figure 90. Latin America Antibody Therapeutics Market (US$ Mn), by Antibody-Drug Conjugates (ADCs), 2020-2034
      • Figure 91. Latin America Antibody Therapeutics Market Analysis, By Source, 2020, 2024 and 2034
      • Figure 92. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Source
      • Figure 93. Latin America Antibody Therapeutics Market (US$ Mn), by Human mAb, 2020-2034
      • Figure 94. Latin America Antibody Therapeutics Market (US$ Mn), by Murine mAb, 2020-2034
      • Figure 95. Latin America Antibody Therapeutics Market (US$ Mn), by Humanized mAb, 2020-2034
      • Figure 96. Latin America Antibody Therapeutics Market (US$ Mn), by Chimeric mAb, 2020-2034
      • Figure 97. Latin America Antibody Therapeutics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 98. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Application
      • Figure 99. Latin America Antibody Therapeutics Market (US$ Mn), by Cancer, 2020-2034
      • Figure 100. Latin America Antibody Therapeutics Market (US$ Mn), by Inflammatory Diseases, 2020-2034
      • Figure 101. Latin America Antibody Therapeutics Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 102. Latin America Antibody Therapeutics Market (US$ Mn), by Autoimmune Diseases, 2020-2034
      • Figure 103. Latin America Antibody Therapeutics Market (US$ Mn), by Others, 2020-2034
      • Figure 104. Latin America Antibody Therapeutics Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 105. Latin America Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • Figure 106. Latin America Antibody Therapeutics Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 107. Latin America Antibody Therapeutics Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 108. Latin America Antibody Therapeutics Market (US$ Mn), by Online Pharmacy, 2020-2034
      • Figure 109. Latin America Antibody Therapeutics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 110. Latin America Antibody Therapeutics Market Attractiveness Analysis, By Country
      • Figure 111. Middle East & Africa Antibody Therapeutics Market Analysis, By Product Type, 2020, 2024 and 2034
      • Figure 112. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Product Type
      • Figure 113. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Monoclonal Antibodies (mAbs), 2020-2034
      • Figure 114. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Antibody-Drug Conjugates (ADCs), 2020-2034
      • Figure 115. Middle East & Africa Antibody Therapeutics Market Analysis, By Source, 2020, 2024 and 2034
      • Figure 116. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Source
      • Figure 117. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Human mAb, 2020-2034
      • Figure 118. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Murine mAb, 2020-2034
      • Figure 119. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Humanized mAb, 2020-2034
      • Figure 120. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Chimeric mAb, 2020-2034
      • Figure 121. Middle East & Africa Antibody Therapeutics Market Analysis, By Application, 2020, 2024 and 2034
      • Figure 122. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Application
      • Figure 123. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Cancer, 2020-2034
      • Figure 124. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Inflammatory Diseases, 2020-2034
      • Figure 125. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Infectious Diseases, 2020-2034
      • Figure 126. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Autoimmune Diseases, 2020-2034
      • Figure 127. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Others, 2020-2034
      • Figure 128. Middle East & Africa Antibody Therapeutics Market Analysis, By End-user, 2020, 2024 and 2034
      • Figure 129. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By End-user
      • Figure 130. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Hospital Pharmacy, 2020-2034
      • Figure 131. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Retail Pharmacy, 2020-2034
      • Figure 132. Middle East & Africa Antibody Therapeutics Market (US$ Mn), by Online Pharmacy, 2020-2034
      • Figure 133. Middle East & Africa Antibody Therapeutics Market Analysis, By Country, 2020, 2024 and 2034
      • Figure 134. Middle East & Africa Antibody Therapeutics Market Attractiveness Analysis, By Country

Related Reports

Our Clients

  • Our Clients
Antibody Therapeutics Market
  • 130808
  • June 2025
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Find Help
Legal
Explore
Secured Payment Options
Secured Payment Options